Stealth BioTherapeutics Company

Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function.
Technology: Geroscience
Industry: Oxidative Phosphorylation
Headquarters: United States
Founded Date: 2007
Employees Number: 101-250
Funding Status: IPO
Investors Number: 8
Total Funding: $120M
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Equity

Visit Website
info@stealthbt.com
https://twitter.com/StealthBT
Register and Claim Ownership